LOTUSENZA ® (letrozole) LOTUS HK Reg. No. HK68544 (16 Jan, 2025) Composition: 1 • Yellow, circular, biconvex film-coated tablets, plain on both sides • Each tablet contains 2.5 mg letrozole Indication: 1 • Adjuvant treatment of po...

Multiple myeloma (MM) is a clonal plasma cell disorder characterised by excess production of monoclonal immunoglobulins and light chains that can ultimately lead to specific end-organ damage 1 . Notably, MM is the second most common haematologic mal...

Prostate cancer (PCa) is a complex disease that affects millions of males, globally. It is the 3rd most common cancer in males and the 4th leading cause of male cancer-related deaths in Hong Kong1. The aetiology of PCa is believed to be related to s...